Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
17.47
-0.86 (-4.69%)
At close: Jan 15, 2026, 4:00 PM EST
17.76
+0.29 (1.66%)
Pre-market: Jan 16, 2026, 7:06 AM EST
| Period Ending | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Mar 31, 2025 | Mar 31, 2025 | Dec 31, 2024 | Dec 31, 2024 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Mar 31, 2024 | Mar 31, 2024 | Dec 31, 2023 | Dec 31, 2023 | Dec 31, 2023 | Sep 30, 2023 | Sep 30, 2023 | Sep 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Mar 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Dec 31, 2022 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software Products and Services | 209.92M | 209.92M | 209.92M | 200.94M | 200.94M | 200.94M | 195.80M | 195.80M | 195.80M | 180.40M | 180.40M | 180.40M | 169.40M | 169.40M | 169.40M | 166.42M | 166.42M | 166.42M | 160.37M | 160.37M | 160.37M | 159.17M | 159.17M | 159.17M | ||||||||||||
| Software Products and Services Growth | 23.92% | 23.92% | 23.92% | 20.74% | 20.74% | 20.74% | 22.09% | 22.09% | 22.09% | 13.34% | 13.34% | 13.34% | 22.52% | 22.52% | 22.52% | 24.17% | 24.17% | 24.17% | 19.07% | 19.07% | 19.07% | 17.42% | 17.42% | 17.42% | ||||||||||||
| Drug Discovery | 47.12M | 47.12M | 47.12M | 37.06M | 37.06M | 37.06M | 34.77M | 34.77M | 34.77M | 27.22M | 27.22M | 27.22M | 24.02M | 24.02M | 24.02M | 34.28M | 34.28M | 34.28M | 28.19M | 28.19M | 28.19M | 57.57M | 57.57M | 57.57M | ||||||||||||
| Drug Discovery Growth | 96.16% | 96.16% | 96.16% | 8.10% | 8.10% | 8.10% | 23.37% | 23.37% | 23.37% | -52.72% | -52.72% | -52.72% | -60.67% | -60.67% | -60.67% | -42.60% | -42.60% | -42.60% | -54.79% | -54.79% | -54.79% | 26.94% | 26.94% | 26.94% |
| Period Ending | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Mar 31, 2025 | Mar 31, 2025 | Dec 31, 2024 | Dec 31, 2024 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Mar 31, 2024 | Mar 31, 2024 | Dec 31, 2023 | Dec 31, 2023 | Dec 31, 2023 | Sep 30, 2023 | Sep 30, 2023 | Sep 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Mar 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Dec 31, 2022 | Dec 31, 2022 | Sep 30, 2022 | Sep 30, 2022 | Sep 30, 2022 | Jun 30, 2022 | Jun 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software Products and Services | 27.26M | 27.26M | 27.26M | 27.13M | 27.13M | 27.13M | 26.27M | 26.27M | 26.27M | |||||||||||||||||||||||||||||||||
| Software Products and Services Growth | 0.40% | 0.40% | 0.40% | 6.96% | 6.96% | 6.96% | 13.80% | 13.80% | 13.80% | |||||||||||||||||||||||||||||||||
| Software Contribution | 18.18M | 18.18M | 18.18M | 16.37M | 16.37M | 16.37M | 13.66M | 13.66M | 13.66M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Drug Discovery | 7.15M | 7.15M | 7.15M | 9.03M | 9.03M | 9.03M | 7.96M | 7.96M | 7.96M | |||||||||||||||||||||||||||||||||
| Drug Discovery Growth | -16.15% | -16.15% | -16.15% | 7.57% | 7.57% | 7.57% | -8.59% | -8.59% | -8.59% |
| Period Ending | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Mar 31, 2025 | Mar 31, 2025 | Dec 31, 2024 | Dec 31, 2024 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Mar 31, 2024 | Mar 31, 2024 | Dec 31, 2023 | Dec 31, 2023 | Dec 31, 2023 | Sep 30, 2023 | Sep 30, 2023 | Sep 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Mar 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Dec 31, 2022 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Discovery Services Customer Contracts | 45.32M | 45.32M | 45.32M | 35.12M | 35.12M | 35.12M | 32.69M | 32.69M | 32.69M | 25.14M | 25.14M | 25.14M | 21.97M | 21.97M | 21.97M | 31.88M | 31.88M | 31.88M | 25.61M | 25.61M | 25.61M | 54.72M | 54.72M | 54.72M | ||||||||||||
| Drug Discovery Services Customer Contracts Growth | 106.30% | 106.30% | 106.30% | 10.16% | 10.16% | 10.16% | 27.64% | 27.64% | 27.64% | -54.05% | -54.05% | -54.05% | -62.27% | -62.27% | -62.27% | -44.26% | -44.26% | -44.26% | -57.31% | -57.31% | -57.31% | 26.00% | 26.00% | 26.00% | ||||||||||||
| Drug Discovery Contribution | 1.76M | 1.76M | 1.76M | 1.89M | 1.89M | 1.89M | 2.04M | 2.04M | 2.04M | 2.03M | 2.03M | 2.03M | 2.02M | 2.02M | 2.02M | 2.37M | 2.37M | 2.37M | 2.55M | 2.55M | 2.55M | 2.82M | 2.82M | 2.82M | ||||||||||||
| Drug Discovery Contribution Growth | -13.29% | -13.29% | -13.29% | -20.12% | -20.12% | -20.12% | -19.95% | -19.95% | -19.95% | -28.03% | -28.03% | -28.03% | -29.72% | -29.72% | -29.72% | -6.89% | -6.89% | -6.89% | 7.24% | 7.24% | 7.24% | 44.72% | 44.72% | 44.72% |
| Period Ending | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Mar 31, 2025 | Mar 31, 2025 | Dec 31, 2024 | Dec 31, 2024 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Mar 31, 2024 | Mar 31, 2024 | Dec 31, 2023 | Dec 31, 2023 | Dec 31, 2023 | Sep 30, 2023 | Sep 30, 2023 | Sep 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Mar 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Dec 31, 2022 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 131.30M | 131.30M | 131.30M | 124.59M | 124.59M | 124.59M | 121.24M | 121.24M | 121.24M | 114.87M | 114.87M | 114.87M | 133.14M | 133.14M | 133.14M | 141.65M | 141.65M | 141.65M | 134.91M | 134.91M | 134.91M | 161.96M | 161.96M | 161.96M | ||||||||||||
| United States Growth | -1.39% | -1.39% | -1.39% | -12.05% | -12.05% | -12.05% | -10.14% | -10.14% | -10.14% | -29.08% | -29.08% | -29.08% | -8.89% | -8.89% | -8.89% | 0.83% | 0.83% | 0.83% | -6.07% | -6.07% | -6.07% | 31.08% | 31.08% | 31.08% | ||||||||||||
| EMEA | 91.28M | 91.28M | 91.28M | 80.70M | 80.70M | 80.70M | 81.54M | 81.54M | 81.54M | 65.65M | 65.65M | 65.65M | 33.86M | 33.86M | 33.86M | 32.48M | 32.48M | 32.48M | 29.50M | 29.50M | 29.50M | 29.14M | 29.14M | 29.14M | ||||||||||||
| EMEA Growth | 169.56% | 169.56% | 169.56% | 148.50% | 148.50% | 148.50% | 176.37% | 176.37% | 176.37% | 125.33% | 125.33% | 125.33% | 22.28% | 22.28% | 22.28% | 14.51% | 14.51% | 14.51% | 3.03% | 3.03% | 3.03% | -15.43% | -15.43% | -15.43% | ||||||||||||
| APAC | 32.70M | 32.70M | 32.70M | 31.23M | 31.23M | 31.23M | 26.38M | 26.38M | 26.38M | 25.80M | 25.80M | 25.80M | 25.18M | 25.18M | 25.18M | 25.47M | 25.47M | 25.47M | 23.00M | 23.00M | 23.00M | 24.57M | 24.57M | 24.57M | ||||||||||||
| APAC Growth | 29.87% | 29.87% | 29.87% | 22.62% | 22.62% | 22.62% | 14.69% | 14.69% | 14.69% | 5.02% | 5.02% | 5.02% | -19.14% | -19.14% | -19.14% | -16.40% | -16.40% | -16.40% | -15.44% | -15.44% | -15.44% | 13.33% | 13.33% | 13.33% | ||||||||||||
| Rest of World | 1.67M | 1.67M | 1.67M | 1.40M | 1.40M | 1.40M | 1.35M | 1.35M | 1.35M | 1.22M | 1.22M | 1.22M | 1.16M | 1.16M | 1.16M | 1.03M | 1.03M | 1.03M | 1.07M | 1.07M | 1.07M | 1.00M | 1.00M | 1.00M | ||||||||||||
| Rest of World Growth | 44.18% | 44.18% | 44.18% | 35.43% | 35.43% | 35.43% | 25.94% | 25.94% | 25.94% | 21.68% | 21.68% | 21.68% | - | - | - | - | - | - | - | - | - | -21.06% | -21.06% | -21.06% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.